TABLE 1

Demographics and clinical characteristics of remote monitoring cohort

All cohort (n=18)No re-admission (n=14)Re-admission (n=4)
Age (years)48 (41–60)46 (37–57)56 (48–63)
Male12 (66.6%)11 (78.5%)1 (25%)
Female6 (33.3%)3 (21.5%)3 (75%)
Current smoker1 (5.5%)1 (7.1%)0 (0%)
Ex-smoker5 (2.7%)4 (28.5%)1 (25%)
Interval between symptom onset and admission (days)9 (5.75–11.25)8.5 (4.25–10.5)10 (8.25–13.25)
Length of initial hospital admission (days)8 (5.5–11.5)10 (6.75–12.25)4 (3–7)
Required supplemental oxygen16 (89%)13 (92.8%)3 (75%)
ICU admission4 (22%)4 (28.5%)0 (0%)
Mechanical ventilation0 (0%)0 (0%)0 (0%)
NIV5 (27%)5 (35.7%)0 (0%)
Received Hydroxychloroquine and Azithromycin13 (72%)10 (71.4%)3 (75%)
Time on home monitor (days)12 (9.75–18)12.5 (10–18)5.5 (2–10)
Median number of data inputs46.5 (27.25–68.75)51 (37.25–68.75)10.5 (4.5–99.75)
Mean number of data inputs per day4.583.995.7
Median SpO2 (all data)96% (95.75%–97%)96% (96%–97%)94.5% (92.5%–96%)
Median number of alerts1 (0.5–4.5)1 (0–4)3 (1.25–14.5)
Median SpO2 of alerts92% (92%–93%)93% (92–93%)91.5% (89.5%–92%)

All data is presented as absolute number and percentage or as median with interquartile range in parenthesis. Data for re-admission patients relates to the initial hospital admission only. Abbreviations: ICU: Intensive Care Unit; NIV: non-invasive ventilation; SpO2: peripheral capillary oxygen saturation.